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ABSTRACT 
Although essentially not all therapies need drug intervention, drugs is still an important components in health sector, 
either in preventive, curative, rehabilitative or promotion efforts. Hence the access to drugs is a main problem, either in 
international or national scale even to the smallest unit. The problem on access to drugs is very complicated and can 
not be separated especially from pharmacy management problems; moreover in general from the overall lack of policy 
development and effective of health policy, and also the implementation process. With the policy development and effective 
health policy, rational drug uses, sufficient health service budget so a country can overcome the health problems. Besides 
infrastructures, regulations, distribution and cultural influences; the main obstacles for drug access is drugs affordability if 
the price of drugs is an important part and detem1ined by many factors, especially the drug status whether is still patent or 
generics that significantly decrease cost of health cares and enhance the drugs affordability. The determination of essential 
drug prices in developing countries should based on equity principal so that poor people pay cheaper and could afford 
the essential drugs. WHO predicts two third of world population can not afford the essential drugs in which in developing 
countries, some are because of inefficient budget allocation in consequence of drug distribution management, including 
incorrect selection and allocation and also irrational uses. In part these could be overcome by enhancing performances 
on the allocation pharmacy needs, including the management of information system, inventory management, stock 
management and the distribution. 
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INTRODUCTION 
The fundamental interrelationship between the 
"state of development" and the "state of health" of 
a nation and its population has been well known 
for years. Poor health is not only a component and 
consequence of poverty but also a cause of it, and 
hence the main obstacle to sustainable development. 
The state of health of an individual conditions the 
person's quality of life, productivity, earnings, and 
thus all other determinants of living standard. Ill health 
therefore represents not only sickness but also an 
economic calamity. The connection between health 
and nutritional status, for example, has a measurable 
impact on learning ability and adult intellectual 
capabilities-which again are long-run determinants 
of adult productivity and earning capacity. 
Although not every treatment needs a drug 
intervention, drug is surely an essential component 
in preventive, curative, rehabilitative or promotive 
health. Therefore access to drugs is a cruc1al issue 
both internationally and nationally. Access to drugs 
certainly can not be separated from pharmaceutical 
management system. Despite 50 years development 
in pharmaceutical products, millions of people in 
developing countries do not have access to even basic 
essential drugs and world widely die each year from 
diseases such as malaria, tuberculosis, and more 
recently, HIV/AIDS. 
Most infectious diseases-which account for 
death and child mortality in low-income countries-can 
be controlled with available and affordable medicines 
and tools , all of which are off-patent. 1 The Wl:iO 
estimates that one-third of the world's population lacks 
access to essential drugs. Regrettably, a significant 
portion of pharmaceutical expenditures in developing 
countries is wasted due to inefficiencies associated 
with the management of drug supplies. including 
inappropriate selection, procurement and rational 
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